Table of Contents >> Show >> Hide
- Why Cervical Cancer Still Matters
- Story One: Lucy Towler and the Long Wait for Answers
- Story Two: Ana Menjivar Centeno and the Cost of Delay
- What Cervical Cancer Usually Feels Like Or Does Not
- How Screening Can Catch Trouble Before Cancer Does
- How Cervical Cancer Is Diagnosed and Treated
- The Emotional Reality No Scan Report Fully Captures
- Additional Real-World Experiences Women Commonly Share After a Cervical Cancer Diagnosis
- Final Thoughts
Cervical cancer has a frustrating personality trait: it can stay quiet for a long time, then suddenly show up like an uninvited guest who somehow also has a medical degree in chaos. That silence is exactly what makes screening, follow-up care, and fast action so important. It is also why real patient stories matter. Statistics can explain what cervical cancer is, but stories explain what it feels like when life gets split into two timelines: before the diagnosis and after it.
In this article, we look at the publicly shared experiences of two women who faced cervical cancer in very different ways. One spent months trying to get answers while worrying that time was slipping away. The other had regular checkups, got an abnormal result, and still saw her cancer progress after delaying treatment. Their stories are different in detail, but they meet in the same place: cervical cancer is not just a diagnosis on paper. It affects your body, your schedule, your fertility plans, your confidence, your family, and the way you hear every phone call from a doctor’s office.
Along the way, we will also break down the medical facts in plain English: what cervical cancer is, how it is usually found, what symptoms to watch for, how treatment works, and why prevention still gives this disease its toughest competition.
Why Cervical Cancer Still Matters
Cervical cancer is far more preventable than many people realize, yet it still takes lives in the United States every year. Most cervical cancers are linked to persistent infection with high-risk types of human papillomavirus, or HPV. That makes this one of the rare cancers where a vaccine, regular screening, and timely follow-up can change the story before cancer ever gets a speaking role.
And yet, cervical cancer remains a real public health problem. It still affects thousands of women each year, especially those who face barriers to care such as lack of insurance, delayed follow-up, transportation problems, rural access issues, language barriers, or plain old life overload. Because yes, sometimes the obstacle is not medical mystery at all. Sometimes it is child care, missing work, fear, cost, or the emotional exhaustion of navigating a system that does not move fast enough when your mind is screaming, “Can somebody please call me back?”
That gap between what is medically possible and what patients actually experience is where these stories live.
Story One: Lucy Towler and the Long Wait for Answers
Lucy Towler’s public story is memorable because it is so painfully relatable. She had dealt with abnormal Pap tests since she was around 18, so being retested was familiar territory. What changed was the bleeding. After giving birth to her third child in 2020, she kept bleeding for months. At first, like many women would, she was trying to make sense of what her body was doing after pregnancy. But eventually the persistence of the bleeding stopped feeling like an inconvenience and started feeling like a warning.
What followed was one of the most emotionally brutal parts of cancer care: waiting. Lucy described spending nearly four months trying to schedule a biopsy and get answers. That delay left her mentally drained. She worried that if it really was cancer, every day without treatment was another day the disease had to grow. That fear is hard to overstate. When a person suspects something serious is happening, uncertainty can feel heavier than pain.
Once she reached MD Anderson, things moved quickly. A gynecologic oncologist performed a colposcopy and biopsy, and a PET scan followed soon after. The tests showed stage IB cervical cancer confined to the cervix. Surgery was recommended, and because Lucy had already had three children and a long history of abnormal Pap results, she felt relief in finally having a clear plan.
She underwent a hysterectomy in February 2022. The pathology report showed no cancer left, suggesting the biopsy may have removed the entire tumor, although the tissue still revealed a higher-grade cancer that required careful follow-up. Her sentinel lymph nodes looked good, so she did not need chemotherapy or radiation. Physically, her recovery was relatively quick. Emotionally, what stands out is something else: the relief of finally being taken seriously, thoroughly evaluated, and given real answers.
What Lucy’s Story Teaches
Lucy’s experience highlights a simple but critical truth: persistent abnormal bleeding is not something to shrug off, especially when it keeps happening or feels different from your usual pattern. It also shows that “I have had abnormal tests before” should never become a reason to stop paying attention. Familiarity can sometimes dull urgency, and cervical cancer does not award points for acting casual.
Her story also underlines how powerful timely diagnosis can be. Catching cervical cancer while it is still localized opens the door to more treatment options and better odds of recovery. In Lucy’s case, early-stage disease and prompt surgery after evaluation made an enormous difference.
Story Two: Ana Menjivar Centeno and the Cost of Delay
Ana Menjivar Centeno’s public story adds another layer that many readers need to hear: regular checkups matter, but abnormal results must be followed all the way through. Ana had kept up with gynecologic visits and Pap smears. After a 2019 appointment, she was told her test was abnormal and was referred for a colposcopy. Around the same time, she developed unusual vaginal discharge and found herself using sanitary pads every day, which was clearly not normal for her.
During the colposcopy, a doctor noticed a mass right away. Samples were taken, laboratory testing was rushed, and Ana learned within a week that she had cervical cancer. She was referred to gynecologic specialists and told she had stage 1 disease. Doctors explained how chemotherapy and radiation could help, but she did not feel ready to begin treatment immediately.
That delay turned out to matter. After a few months, she returned and learned the cancer had progressed to stage 2. At that point, her team again emphasized the need to start treatment as soon as possible, and she agreed.
Ana then underwent chemotherapy and radiation, including external beam radiation therapy and MRI-guided brachytherapy. Her case was especially notable because she became the first gynecologic cancer patient at that Johns Hopkins-affiliated hospital to receive that MRI-guided brachytherapy approach there. The goal of brachytherapy is to place radiation very close to the tumor while sparing as much nearby healthy tissue as possible. It sounds highly technical because, well, it is. But for patients, what often matters most is the very human side of treatment: being guided, being heard, and not having to fight every logistical battle alone.
Ana spoke positively about the kindness of the nurses and staff, and several months after treatment she was back at work and feeling great. Her story is not a fairy tale wrapped in a pink ribbon. It is better than that. It is honest. She had an abnormal test, symptoms, hesitation, disease progression, intensive treatment, and then recovery with support.
What Ana’s Story Teaches
Ana’s experience drives home that an abnormal Pap test is not the end of the process; it is the beginning of a decision tree. Follow-up matters. So does timing. Eating healthier and taking vitamins can support overall well-being, but they cannot replace evidence-based cancer treatment once cancer is diagnosed. That is not a knock on healthy habits. It is just a reminder that kale is lovely, but it does not perform brachytherapy.
Her story also shows how access to coordinated care can shape the patient experience. When patients do not have to manage every appointment, every referral, and every explanation alone, treatment becomes more doable. In cancer care, “doable” is not a small thing. Sometimes it is the bridge that gets a person from fear to action.
What Cervical Cancer Usually Feels Like Or Does Not
One of the most difficult things about cervical cancer is that early-stage disease often causes no symptoms at all. That is why many women feel blindsided by the diagnosis. They were not “ignoring obvious signs.” There often were no obvious signs. Cervical cancer can be quiet in the beginning, which is exactly why screening exists.
When symptoms do happen, they often include abnormal vaginal bleeding, bleeding after sex, bleeding between periods, postmenopausal bleeding, unusual vaginal discharge, pelvic pain, and pain during sex. These symptoms do not automatically mean cancer. They can be caused by other conditions too. But they do mean something deserves evaluation.
If there is one lesson readers should carry out of this section like a fire drill clipboard, it is this: unusual bleeding is worth getting checked. Not next year. Not after three more internet searches. Not after your calendar calms down. Promptly.
How Screening Can Catch Trouble Before Cancer Does
Cervical cancer screening is designed to find precancerous cell changes before they become invasive cancer, or to catch cancer early when treatment is more likely to work well. In the United States, the tools typically used are the Pap test, the HPV test, or both together.
The Pap test looks for abnormal cell changes in the cervix. The HPV test looks for high-risk HPV types that can cause those changes. If a result is abnormal, the next steps may include repeat testing, a colposcopy, or a biopsy depending on age, history, and the exact results.
Screening recommendations vary a bit depending on which professional organization you follow and on a person’s individual risk. In general, U.S. guidance recommends beginning screening in early adulthood, with HPV-based screening becoming especially important from the mid-20s onward. The broader point is more important than memorizing every interval: regular screening saves lives, and even people who have had the HPV vaccine still need screening because the vaccine does not protect against every cancer-causing HPV type.
It is also worth saying out loud that an abnormal screening result is scary, but it is not automatically a cancer diagnosis. In many cases, abnormal results reflect HPV infection or precancerous changes that can be monitored or treated before cancer develops. That is the whole point of screening: finding problems early enough to stop them from becoming bigger ones.
How Cervical Cancer Is Diagnosed and Treated
When doctors suspect cervical cancer, they usually begin with a history, pelvic examination, cervical cytology, HPV testing, colposcopy, and biopsy. If cancer is confirmed, imaging and staging help determine whether the disease is confined to the cervix or has spread to nearby tissues, lymph nodes, or more distant parts of the body.
Treatment depends heavily on stage. For the earliest stages, surgery may be an option. In other cases, especially more locally advanced disease, radiation combined with chemotherapy is often the main approach. Brachytherapy is a key part of treatment for many patients receiving radiation because it delivers radiation close to the tumor. For advanced or metastatic disease, treatment may include chemotherapy, targeted therapy, and immunotherapy depending on the tumor’s features.
Survival is much better when cervical cancer is found early. That is not meant to scare anyone; it is meant to clarify why screening and fast follow-up matter so much. Early-stage, localized cervical cancer has far better outcomes than disease found after it has spread regionally or distantly.
Another important issue is fertility. Some cervical cancer treatments can affect fertility permanently, and for younger patients this can be one of the most painful parts of the diagnosis. When possible, fertility preservation discussions should happen before treatment begins. Not after. Before. That conversation may involve options like egg, embryo, or ovarian tissue preservation, depending on the clinical situation. For some patients, fertility-sparing treatment may be possible, but that depends on tumor size, stage, and other medical details.
The Emotional Reality No Scan Report Fully Captures
Cervical cancer is not only a disease of the cervix. It quickly becomes a disease of calendars, relationships, waiting rooms, and mental bandwidth. Women often describe a swirl of emotions: fear, guilt, anger, embarrassment, numbness, and the exhausting pressure to stay strong for everyone else. Because cervical cancer is so closely linked to HPV, stigma can also creep in, even though HPV infection is common and should not be treated as a moral scorecard.
Treatment can bring fatigue, bowel or bladder changes, menopause-related symptoms, sexual side effects, body-image concerns, and anxiety about follow-up scans. Even when treatment ends, the experience does not simply vanish like a hospital wristband tossed in the trash. Survivorship often includes regular follow-up appointments, vigilance about symptoms, and the strange emotional whiplash of trying to feel normal while also knowing exactly how abnormal life can become.
This is where support matters: good communication with clinicians, second opinions when needed, practical help from family or patient navigators, therapy, support groups, and honest conversations about sexuality, fertility, work, and fear. Nobody should have to pretend those topics are side notes. They are part of the real story.
Additional Real-World Experiences Women Commonly Share After a Cervical Cancer Diagnosis
Ask enough women about cervical cancer, and certain themes keep coming back. First, many say the diagnosis itself feels surreal. One minute they are scheduling regular life things like grocery runs, school pickups, and overdue dentist appointments. The next, they are learning new words such as colposcopy, staging, external beam radiation, and brachytherapy. It is a strange education nobody ever wanted.
Second, many women describe how quickly a private body part becomes the center of very public logistics. Suddenly there are forms, scans, referrals, insurance calls, and conversations with bosses, partners, relatives, and sometimes children. The illness may be physically located in the cervix, but the disruption spreads everywhere.
Another experience women often describe is the emotional weight of waiting. Waiting for biopsy results. Waiting for scans. Waiting to hear whether treatment worked. Waiting at follow-up appointments while trying to act calm even though your nervous system is doing cartwheels in dress shoes. That anxiety can be intense even when the news is good. Many survivors say they learn to live in shorter emotional increments, focusing on the next appointment instead of trying to mentally solve the next five years before lunch.
Women also talk about the challenge of feeling “fine enough” to confuse the people around them. Cervical cancer does not always look dramatic from the outside. A person may still be answering emails, smiling in family photos, or loading the dishwasher while carrying enormous fear internally. That mismatch can leave patients feeling unseen. They may hear, “But you look great,” when what they really need is, “This is hard, and I’m here.”
For some, treatment affects intimacy, body confidence, or fertility in ways that are deeply personal and difficult to explain. For others, it changes how they think about prevention. Women who once put off screenings because they were busy, nervous, uninsured, or simply overwhelmed often become fierce advocates for regular care afterward. They remind friends to keep appointments, follow up abnormal tests, and ask questions until they understand the answer.
And then there is the surprising part many survivors mention: gratitude and grief can exist at the same time. A woman can be relieved to be cancer-free and still angry about what treatment cost her. She can be thankful for her doctors and still shaken by the memory of diagnosis day. She can return to work, laugh with friends, and still feel a spike of panic before every surveillance scan. None of that means she is coping badly. It means she is human.
That may be the most important takeaway from all: cervical cancer stories are not only about disease. They are about endurance, adaptation, support, and the very ordinary courage required to keep going when life becomes medically complicated. Sometimes courage looks dramatic. Sometimes it looks like showing up for a follow-up appointment you really do not want to attend. Both count.
Final Thoughts
The stories of Lucy Towler and Ana Menjivar Centeno show that cervical cancer is never just a clinical diagnosis. It is a lived experience shaped by symptoms, timing, access, treatment decisions, and the people who help a patient through it. Their stories also reinforce two messages that public health experts have been trying to make very clear for years: screening works, and follow-up matters.
Cervical cancer can often be prevented or found early, but only when abnormal results are not ignored, symptoms are evaluated promptly, and patients have access to real care instead of endless delays. If there is a hopeful message here, it is not fake optimism. It is something sturdier: this is a cancer with tools on our side. HPV vaccination helps prevent it. Screening can catch it early or even stop it before it starts. Treatment keeps improving. And patient stories keep reminding the rest of us that paying attention can save a life.
In other words, the cervix may be small, but ignoring it is a very bad strategy.